{"entity":{"id":"adda-bounedjar","kind":"person","name":"Adda Bounedjar","aka":[],"tldr":"Adda Bounedjar represents Anti-Cancer Center of Blida in the Organisation of European Cancer Institutes, which lists the organisation among its members in Algeria.","summary":"Adda Bounedjar is listed by the Organisation of European Cancer Institutes (OECI) as the representative of Anti-Cancer Center of Blida, its associate member in Algeria. OnCo records the name from the OECI membership list so that the organisation's page names its contact within Europe's cancer-centre network; the person's clinical or management role is not stated by the list and should be checked at the organisation's website.","asOf":"2026-09-10","links":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"Anti-Cancer Center of Blida website","url":"https://ehs-clccblida.dz"}],"tags":["oeci-representative","leader"],"related":["oeci"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["blida-anti-cancer-center"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Representative of Anti-Cancer Center of Blida to the Organisation of European Cancer Institutes","institutionId":"blida-anti-cancer-center","specialisms":["Cancer centre representation (OECI)"],"profiles":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"Anti-Cancer Center of Blida website","url":"https://ehs-clccblida.dz"}],"papers":[{"title":"A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries","journal":"Eur J Cancer","year":2020,"url":"https://doi.org/10.1016/j.ejca.2020.05.015","doi":"10.1016/j.ejca.2020.05.015","note":"Europe PMC author record matched by affiliation"},{"title":"Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial","journal":"J Cancer Res Clin Oncol","year":2023,"url":"https://doi.org/10.1007/s00432-023-04588-3","doi":"10.1007/s00432-023-04588-3","note":"Europe PMC author record matched by affiliation"},{"title":"Africa Guidelines for Hepatocellular Carcinoma Buildup Process","journal":"JCO Glob Oncol","year":2023,"url":"https://doi.org/10.1200/go.23.00159","doi":"10.1200/go.23.00159","note":"Europe PMC author record matched by affiliation"}]},"route":"/people/adda-bounedjar/","neighbours":{"institution":[{"id":"blida-anti-cancer-center","kind":"institution","name":"Anti-Cancer Center of Blida","route":"/institutions/blida-anti-cancer-center/"},{"id":"oeci","kind":"institution","name":"Organisation of European Cancer Institutes","route":"/institutions/oeci/"}]}}